99 related articles for article (PubMed ID: 7992081)
1. Clinical experience with somatostatin receptor imaging in lymphoma.
Bong SB; VanderLaan JG; Louwes H; Schuurman JJ
Semin Oncol; 1994 Oct; 21(5 Suppl 13):46-50. PubMed ID: 7992081
[No Abstract] [Full Text] [Related]
2. Somatostatin receptor-based imaging in malignant lymphomas.
O'Brien JP
J Nucl Med; 1995 Jan; 36(1):19-20. PubMed ID: 7799074
[No Abstract] [Full Text] [Related]
3. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.
Lipp RW; Silly H; Ranner G; Dobnig H; Passath A; Leb G; Krejs GJ
J Nucl Med; 1995 Jan; 36(1):13-8. PubMed ID: 7799065
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor imaging.
Kwekkeboom DJ; Krenning EP
Semin Nucl Med; 2002 Apr; 32(2):84-91. PubMed ID: 11965603
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history.
Krenning EP; Kooij PP; Bakker WH; Breeman WA; Postema PT; Kwekkeboom DJ; Oei HY; de Jong M; Visser TJ; Reijs AE
Ann N Y Acad Sci; 1994 Sep; 733():496-506. PubMed ID: 7978900
[No Abstract] [Full Text] [Related]
6. Somatostatin-receptor imaging in lymphoma.
Goldsmith SJ; Macapinlac HA; O'Brien JP
Semin Nucl Med; 1995 Jul; 25(3):262-71. PubMed ID: 7570045
[TBL] [Abstract][Full Text] [Related]
7. [A case of metastatic gastrinomas in the liver visualized by 111In-DTPA-D-Phe-octreotide (111In-pentetreotide)].
Tani A; Nakabeppu Y; Tsuchimochi S; Nakajo M; Yoshinaga T; Kiku T
Kaku Igaku; 1996 May; 33(5):545-9. PubMed ID: 8699623
[TBL] [Abstract][Full Text] [Related]
8. [Complementary scintigraphic examinations (99mTc-MDP, 99mTc-MIBI and Octreoscan) in breast neoplasm assessment].
Stefănescu C; Chossiere L; Rusu V; Meignan M
Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):165-8. PubMed ID: 9455458
[TBL] [Abstract][Full Text] [Related]
9. An unusual visualization of the gallbladder by somatostatin receptor (SSTR) scintigraphy: usefulness of hepatobiliary imaging for differential diagnosis.
Kurtaran A; Ofluoglu S; Traub T; Tribl B; Speiser P; Grabenwöger F; Schima W; Dudczak R; Virgolini I
Am J Gastroenterol; 2000 May; 95(5):1367-8. PubMed ID: 10811361
[No Abstract] [Full Text] [Related]
10. Imaging of a mediastinal thymic carcinoid tumor with radiolabeled somatostatin analogue.
Cadigan DG; Hollett PD; Collingwood PW; Ur E
Clin Nucl Med; 1996 Jun; 21(6):487-8. PubMed ID: 8744192
[No Abstract] [Full Text] [Related]
11. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
Wiedenmann B; Bäder HM; Scherubl H; Fett U; Zimmer T; Hamm B; Koppenhagen K; Riecken EO
Semin Oncol; 1994 Oct; 21(5 Suppl 13):29-32. PubMed ID: 7992077
[No Abstract] [Full Text] [Related]
12. Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide.
Krenning EP; Kwekkeboom DJ; de Jong M; Visser TJ; Reubi JC; Bakker WH; Kooij PP; Lamberts SW
Semin Oncol; 1994 Oct; 21(5 Suppl 13):6-14. PubMed ID: 7992084
[No Abstract] [Full Text] [Related]
13. Somatostatin and the concept of peptide receptor scintigraphy in oncology.
Lamberts SW; Reubi JC; Krenning EP
Semin Oncol; 1994 Oct; 21(5 Suppl 13):1-5. PubMed ID: 7992074
[No Abstract] [Full Text] [Related]
14. Octreotide uptake in the head and neck.
Horn JD; Gordon BM; Gordon L; Spicer KM
Semin Nucl Med; 1997 Jan; 27(1):79-81. PubMed ID: 9122727
[No Abstract] [Full Text] [Related]
15. Somatostatin receptor scintigraphy (SRS): a new diagnostic tool in neuroblastoma (NB)?
Dörr U; Sautter-Bihl ML; Schilling FH; Koscielniak E; Treuner J; Bihl H
Prog Clin Biol Res; 1994; 385():355-61. PubMed ID: 7972231
[No Abstract] [Full Text] [Related]
16. Somatostatin receptors in meningiomas: a scintigraphic study using 111In-DTPA-D-Phe-1-octreotide.
Maini CL; Tofani A; Sciuto R; Carapella C; Cioffi R; Crecco M
Nucl Med Commun; 1993 Jul; 14(7):550-8. PubMed ID: 8355914
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor imaging: a new horizon in the diagnostic management of neuroblastoma.
Sautter-Bihl ML; Dörr U; Schilling F; Treuner J; Bihl H
Semin Oncol; 1994 Oct; 21(5 Suppl 13):38-41. PubMed ID: 7992079
[No Abstract] [Full Text] [Related]
18. Somatostatin-receptor scintigraphy in Graves' orbitopathy.
Postema PT; Kwekkeboom DJ; van Hagen PM; Krenning EP
Eur J Nucl Med; 1996 Jun; 23(6):615-7. PubMed ID: 8662098
[No Abstract] [Full Text] [Related]
19. Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogs.
Dörr U; Wurm K; Höring E; Guzman G; Räth U; Bihl H
Horm Metab Res Suppl; 1993; 27():36-43. PubMed ID: 8330870
[TBL] [Abstract][Full Text] [Related]
20. [Somatostatin receptor scintigraphy. A new imaging procedure for the specific demonstration of carcinoids of the small intestine].
Dörr U; Räth U; Schürmann G; Höring E; Bach D; Wurm K; Scholz M; Adrian HJ; Bihl H
Rofo; 1993 Jan; 158(1):67-73. PubMed ID: 8425079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]